Stockreport

Sensei Biotherapeutics to Host Virtual KOL Event to Discuss Full Dose Expansion Data for Solnerstotug in PD-(L)1 Resistant Tumors on October 20, 2025 [Yahoo! Finance]

Sensei Biotherapeutics, Inc.  (SNSE) 
PDF stage biotechnology company focused on the discovery and development of next-generation therapeutics for cancer patients, today announced that it will host a virtual key [Read more]